SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001437749-13-000966
Filing Date
2013-01-31
Accepted
2013-01-31 17:00:27
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A unigene_10qa-063012.htm 10-Q/A 967728
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 18661
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 18497
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8059
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 8519
  Complete submission text file 0001437749-13-000966.txt   8235129

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS ugne-20120630.xml EX-101.INS 1425949
7 EXHIBIT 101.SCH ugne-20120630.xsd EX-101.SCH 68759
8 EXHIBIT 101.CAL ugne-20120630_cal.xml EX-101.CAL 44526
9 EXHIBIT 101.DEF ugne-20120630_def.xml EX-101.DEF 383053
10 EXHIBIT 101.LAB ugne-20120630_lab.xml EX-101.LAB 444505
11 EXHIBIT 101.PRE ugne-20120630_pre.xml EX-101.PRE 383612
Mailing Address 81 FULTON STREET BOONTON NJ 07005
Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

IRS No.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-16005 | Film No.: 13563352
SIC: 2833 Medicinal Chemicals & Botanical Products